Subscribe to MDT Magazine News

Alcon taps new board chairman

October 24, 2010 3:45 pm | Comments

Eye care company Alcon Inc. said Sunday its board has elected a new chairman to replace Cary Rayment.Daniel Vasella, who is also chairman of the board of Novartis AG, will now take over, the company said. Vasella has served on Alcon's board since July 7, 2008, and Novartis became Alcon's...

Discovery of taste receptors in the lungs could help people with asthma breathe easier

October 24, 2010 11:31 am | by EurekAlert | Comments

(University of Maryland Medical Center) Taste receptors in the lungs? Researchers at the University of Maryland School of Medicine in Baltimore have discovered that bitter taste receptors are not just located in the mouth but also in human lungs. What they learned about the role of the...


NCPA Announces Kathleen Jaeger as CEO

October 24, 2010 10:34 am | by Bio-Medicine.Org | Comments

ALEXANDRIA, Va., Oct. 24 /PRNewswire-USNewswire/ -- The National Community Pharmacists Association (NCPA) today announced the appointment of Kathleen Jaeger as Executive Vice President and CEO, heralding her as an ideal choice to build on the association's recent accomplishments and lead...


Hyland’s Teething Tablets: Recall - Risk of Harm to Children

October 23, 2010 8:32 pm | by U.S. Food & Drug Administration | Comments

FDA laboratory analysis found product to contain inconsistent amounts of belladonna, which can cause harm at larger doses.

Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA

October 23, 2010 9:31 am | by Bio-Medicine.Org | Comments

SAN DIEGO, Oct. 23 /- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR ) announced today the presentation of combined data from its two fidaxomicin Phase 3 trials in patients with Clostridium difficile infection (CDI) at the 48th Annual Meeting of the Infectious Disease Society of America...


FDA Issues Complete Response Letter for Lorcaserin New Drug Application

October 23, 2010 12:31 am | by Bio-Medicine.Org | Comments

SAN DIEGO and WOODCLIFF LAKE, N.J., Oct. 23, 2010 /- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) and Eisai Inc. announced that the US Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding Arena's New Drug Application (NDA) for lorcaserin. Lorcaserin is...


VCA Antech 3Q profit drops, misses expectations

October 22, 2010 2:45 pm | by The Associated Press | Comments

VCA Antech Inc., which owns and operates veterinary hospitals and laboratories and sells premium and therapeutic pet food, said Friday that its third-quarter profit fell 25 percent as costs and expenses rose, missing analyst expectations.For July through September, VCA Antech earned $27.4...

Ventas to buy Atria real estate assets for $1.5B

October 22, 2010 11:45 am | by The Associated Press | Comments

Ventas Inc. said Friday it is buying the real estate assets of Atria Senior Living Group for $1.5 billion in cash and stock, giving it a portfolio of 118 homes located in wealthy coastal regions.The healthcare real estate investment trust is also assuming $1.6 billion in debt.Ventas said the...


Health insurers help GOP after dalliance with Dems

October 22, 2010 10:45 am | by JIM KUHNHENN - Associated Press Writers - Associated Press | Comments

Health insurers flirted with Democrats, supported them with money and got what they wanted: a federal mandate that most Americans carry health care coverage. Now they're backing Republicans, hoping a GOP Congress will mean friendlier regulations.They may get more than they're wishing for.The...

Boston biotech finance head Baia dies

October 22, 2010 10:33 am | by Mass High Tech: The Journal of New England Technology | Comments

Anne Baia, financial advisor and interim chief financial offier for several venture-backed Boston-area life sciences companies, died on Oct. 20 from cancer. She was 54 years old.

Europe approves expanded use of Boston Scientific stent

October 22, 2010 10:33 am | by Mass High Tech: The Journal of New England Technology | Comments

Boston Scientific Corp. has received CE approval in Europe for expanded use of its WallFlex Biliary RX Fully Covered Stent for the treatment of benign bile duct strictures.

Fentanyl Transdermal System: Recall - Potential for Active Ingredient to Release Faster Than Specified

October 22, 2010 10:33 am | by U.S. Food & Drug Administration | Comments

Accelerated release of Fentanyl can lead to adverse events for at-risk patients, including excessive sedation, respiratory depression, hypoventilation, and apnea.

Lotus Pharmaceuticals Preparing to Apply for National Exchange Listing

October 22, 2010 9:33 am | by Bio-Medicine.Org | Comments

BEIJING, Oct. 22 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS ) ("Lotus" or the "Company"), a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China ("PRC"), announced today that the...


Bacterin International Holdings, Inc. Schedules Conference Call to Present Third Quarter 2010 Financial Results

October 22, 2010 9:33 am | by Bio-Medicine.Org | Comments

BELGRADE, Mont., Oct. 22 /- Bacterin International Holdings, Inc. (OTC Bulletin Board: BIHI ) ("Bacterin"), announced today that it has scheduled a conference call for Monday, November 15, 2010 at 10:00 a.m. (ET) to discuss the Company's financial results for its third quarter 2010, which...


AdvaMed 2010 Sets New Attendance Record: More than 1,700 Device and Diagnostics Leaders from Across the Country and Around the World Came to Washington, D.C.

October 22, 2010 9:33 am | by Bio-Medicine.Org | Comments

WASHINGTON, Oct. 22 /PRNewswire-USNewswire/ -- More than 1,700 medical device and diagnostics leaders from more than 360 companies – representing 24 countries and 33 states – attended the fourth annual industry gathering, AdvaMed 2010: The MedTech Conference this week in...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.